GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » Net Income From Continuing Operations

Virbac (XPAR:VIRP) Net Income From Continuing Operations : €119 Mil (TTM As of Jun. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Virbac Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Virbac's net income from continuing operations for the six months ended in Jun. 2023 was €75 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was €119 Mil.

Virbac Net Income From Continuing Operations Historical Data

The historical data trend for Virbac's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Net Income From Continuing Operations Chart

Virbac Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.99 54.42 140.34 115.69 121.32

Virbac Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.73 41.96 77.56 43.76 74.77

Virbac Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €119 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virbac (XPAR:VIRP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » Net Income From Continuing Operations
Comparable Companies
XPAR:CAT31 XPAR:ALLEX XPAR:ALVIN XPAR:ALPOU XPAR:ALCOG XPAR:ALWEC XPAR:CRSU XPAR:HCO XPAR:CNDF XPAR:CMO LLY JNJ MRK ABBV LSE:AZN XSWX:NOVN XSWX:ROG AMGN PFE XPAR:SAN
Traded in Other Exchanges
0NM7:UK V16:Germany
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Website
https://www.virbac.com
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (XPAR:VIRP) Headlines

No Headlines